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Background
Halogenative and nitrosative stress are two types of oxida-
tive stress that have been proposed as pathogenic mechan-
isms in Parkinson’s disease (PD). They can be caused by
over-stimulation of phagocytes. We hypothesize that
maintained phagocyte overstimulation leads to both halo-
genative and nitrosative stress in Parkinson’s disease,
which are present in serum and cerebrospinal fluid of
patients. These types of oxidative stress could modify pro-
teins related to the pathogenesis of Parkinson’s disease.
Materials and methods
Halogenative and nitrosative stress-induced protein
changes in serum and CSF were analyzed in PD patients
(n=54) and control subjects without any neurological disor-
der (n=40), by using ELISA, western-blotting, mass spectro-
metry, culture techniques and immunofluorescence.
Results
In our lab, it has been detected the presence of halogena-
tive stress in serum and, to a lesser extent, cerebrospinal
fluid of Parkinsonian patients leading to excess of
advanced oxidized protein products or AOPP. On the
other hand, nitrosative stress is also present in serum and
cerebrospinal fluid of patients with early PD, character-
ized by the selective increase of 3-nitrotyrosine proteins
other than nitroalbumin and free 3-nitrotyrosine. Nitro-
sylation stress is accompanied by modification of the
sites of nitrosylation of a-synuclein in patients with early
PD, characterized by dominant nitrosylation of tyrosine
125/136 residues. In vitro studies revealed that 60K-
filtrated serum from PD patients is cytotoxic for sub-
stanta nigra neurons in culture, and it is able to induce
proteinaceous aggregates inside these neurons, which are
strongly positive to nitro-a-synuclein. Interestingly,
cytotoxicity can be blocked by using antibodies aimed
to nitrosylated tyrosine-39 of the molecule.
Conclusions
Since metabolism of advanced oxidized protein products
and 3-nitrotyrosine proteins has been associated to phago-
cytic overstimulation, this pathological alteration could
play a pathogenic role in sporadic PD. Our observations
also lead to the hypothesis that serum level of advanced
oxidized protein products is a prognostic marker for Par-
kinson’s disease duration, and these oxidized proteins
could participate in neuroinflammation. Besides, the eva-
luation of nitrosative stress through enhanced levels of
3-nitrotyrosine proteins in serum and cerebrospinal fluid
without changes in nitroalbumin, together with the profile
of tyrosine nitrosylation of serum a-synuclein character-
ized by dominant nitrosylation of Tyr125/136 could serve
for diagnosis of sporadic Parkinson’s disease. Nitro-a-synu-
clein is a main component of Lewy bodies, hallmarks of the
disease, and serum nitro-a-synuclein could represent a
pathogenic factor in PD. Finally, we have in vitro evidence
that blockade of tyrosine residue 39 of nitro-a-synuclein
could abolish cytotoxicity of Parkinsonian serum.
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